Skip to content
drillr.ai
Sign up

603939.SH

Yifeng Pharmacy Chain Co., Ltd.

SSE · Healthcare · Medical - Pharmaceuticals · CN

CNY 24.91
−2.58%
Ask drillr

  • Oct 29, 2026, 08:28 UTC

    Yifeng Pharmacy reported revenue of RMB 18.236 billion for the first nine months of 2026, up 5.49% year over year, and net profit attributable to shareholders of RMB 1.362 billion, up 10.36%.

    Source:

  • Oct 29, 2026, 08:28 UTC

    Yifeng Pharmacy reported third-quarter 2026 revenue of RMB 6.106 billion, up 9.73% year over year, and net profit attributable to shareholders of RMB 392 million, up 12.89%.

    Source:

  • Sep 16, 2026, 10:24 UTC

    Yifeng Pharmacy announced a 2026 half-year cash dividend of RMB 0.30 per share to all shareholders, during which conversion of the Yifeng Convertible Bond will be suspended from September 22, 2026 until the record date.

    Source:

  • Sep 1, 2026, 09:07 UTC

    Yifeng Pharmacy announced that as of August 31, 2026, it had repurchased 3.9773 million shares for 89.992 million yuan under its ongoing buyback program.

    Source:

  • Aug 27, 2026, 09:42 UTC

    Yifeng Pharmacy proposed a cash dividend of 0.30 yuan per share (tax included).

    Source:

  • Aug 27, 2026, 09:42 UTC

    Yifeng Pharmacy announced its first-half 2026 results with net profit of 964 million yuan, up 9.51% year-on-year.

    Source:

  • Jul 26, 2026, 05:49 UTC

    Multiple Shanghai-listed companies announced share buyback plans in the week ending July 26, 2026, with total proposed buyback amounts up to 83.86 billion yuan.

    Source:

  • Jul 26, 2026, 05:49 UTC

    Yifeng Pharmacy announced a share buyback plan of 200 million to 300 million yuan on July 24, 2026, for employee stock ownership or equity incentive.

    Source: